Increase in direct diabetes-related costs and resource use in the 6 months following initiation of insulin in patients with type 2 diabetes in five European countries: Data from the INSTIGATE study

ClinicoEconomics and Outcomes Research

Volumn 4, Issue 1, 2012, Pages 383-393

  Jones, Stephen ^a   Castell, Conxa ^b   Goday, Albert ^c   Smith, Helen T ^d   Nicolay, Claudia ^e   Simpson, Alexander ^d   Salaun Martin, Carole ^f  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b Department of Health ^*  (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d ELI LILLY AND COMPANY   (United States)

^e LILLY DEUTSCHLAND GMBH   (Germany)

^f Lilly France   (France)

Author keywords

Costs; Insulin; Resource use; Type 2 diabetes mellitus

Indexed keywords

METFORMIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEMALE; FOLLOW UP; FRANCE; GERMANY; GREECE; HEALTH CARE COST; HOSPITAL COST; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RESOURCE MANAGEMENT; SPAIN; TREATMENT DURATION; UNITED KINGDOM;

EID: 84871640208     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/CEOR.S36148     Document Type: Article

References (21)

1. The International Diabetes Federation. IDF Diabetes Atlas, 4th ed, 2009. Available from: http://www.diabetesatlas.org/content/diabetes-and-impaired-glucose-tolerance. Accessed July 17, 2012.
2. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;35(6):1364-1379.
3. The International Diabetes Federation Europe and Federation of European Nurses in Diabetes, 2008. Diabetes. The policy puzzle: is Europe making progress? Available from: http://www.idf.org/webdata/docs/EU-diabetes-policy-audit-2008.pdf. Accessed July 17, 2012.
4. Jönsson B; For the CODE-2 Advisory Board. Revealing the cost of Type II diabetes in Europe. Diabetologia. 2002;45(7):S5-S12.
5. Rosenblum M, Kane M. Analysis of cost and utilization of health care services before and after initiation of insulin therapy in patients with type 2 diabetes mellitus. J Manag Care Pharm. 2003;9(4):309-316.
6. Liebl A, Jones S, Benroubi M, et al. Clinical outcomes after insulin initiation in patients with type 2 diabetes: 6-month data from the INSTIGATE observational study in five European countries. Curr Med Res Opin. 2011;27(5):887-895.
7. Jones S, Benroubi M, Castell C, et al. Characteristics of patients with type 2 diabetes mellitus initiating insulin therapy: baseline data from the INSTIGATE study. Curr Med Res Opin. 2009;25(3):691-700.
8. Liebl A, Breitscheidel L, Nicolay C, Happich M. Direct costs and health-related resource utilisation in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE Study. Curr Med Res Opin. 2008;24(8):2349-2358.
9. Jönsson B. Revealing the cost of type II diabetes in Europe. Diabetologia. 2002;45(Suppl 7):S5-S12.
10. Agence technique de l'information sur hospitalisation 2003. Available from: http://www.atih.sante.fr/?id=000220000000. Accessed Jan 2007.
11. VIDAL database. Available from: http://www.vidal.fr. Accessed July 17, 2012.
12. Liste des Produits et des Prestations. Available from: http://www.codage.ext.cnamts.fr. Accessed July 17, 2012.
13. Kassenärtzliche Bundesvereiningung. Einheitlicher Bewertungsmaßstab (EBM). Cologne, Germany: Deutscher Ärzte-Verlag; 2006.
14. German Diagnosis Related Groups. DRG database. Available from: http://www.g-drg.de. Accessed July 17, 2012.
15. Schwabe U, Paffrath D. Arzneimittelverordnungsreport. Berlin, Heidelberg, Germany: Springer-Verlag; 2006.
16. Oblikue Consulting. Oblikue database. Available from: http://www.oblikue.com. Accessed July 17, 2012.
17. Catálogo de Especialidades Farmaceuticas, 2006. Available from: http://pfarmals.portalfarma.com/default.asp. Accessed Jan 2007.
18. Department of Health. National Schedule of Reference Costs. Available from: http://www.dh.gov.uk/assetRoot/04/13/32/26/04133226.xls. Accessed Dec 2006.
19. Personal Social Services Research Unit. Unit costs of health and social care 2005 (Chapter 9). Nurses and doctors. Available from: http://www.pssru.ac.uk/archive/pdf/uc/uc2005/uc2005_s09.pdf. Accessed July 17, 2012.
20. British Pharmaceutical Formulary. Available from: http://www.bnf.org. Accessed July 17, 2012.
21. Rosenblum M. Analysis of cost and utilization of health care services before and after initiation of insulin therapy in patients with type 2 diabetes mellitus. J Manag Care Pharm. 2003;9(4):309-316.